Ann: Mesoblast Update on COVID-19 ARDS Trial, page-614

hi@Joannie

Thank you for such a considered response.

I believed from 2010, MSB was going to make my (second) wife and I rich.

I averaged down and up.

I bought all I could during that time. I'm a simple teacher, not a millionaire investor

I believed all the scientific geniuses that posted here.

However, everytime MSB came up to the plate, we struck out. But, it was always someone else's fault. Wrong primary endpoints, NASDAQ aren't Australian, ASX200 inclusion was actually exclusive, Teva handback, they didn't know the full story, LVAD wrong endpoint. Should have been gastrointestinal bleeding, aGVHD ????, should have been a blinded trial, which we knew, CHF wrong primary endpoint, Now Covid, wrong numbers to meet endpoint because someone else changed the standard of care.

Sounds like the dog ate my homework.

Can we realistically, expect any change.

We've only got CLBP left

The track record is not looking too good